High	O
HbA1c	B:C0019018
at	O
onset	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
for	O
future	O
metabolic	O
control	I:C1513158
for	O
the	O
individual	O
child	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854

High	O
HbA1c	O
at	O
onset	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
for	O
future	O
metabolic	B:C1513158
control	I:C1513158
for	O
the	O
individual	O
child	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854

High	O
HbA1c	O
at	O
onset	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
for	O
future	O
metabolic	O
control	I:C1513158
for	O
the	O
individual	B:C0237401
child	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854

High	O
HbA1c	O
at	O
onset	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
for	O
future	O
metabolic	O
control	I:C1513158
for	O
the	O
individual	O
child	O
with	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
mellitus	I:C0011854

To	O
study	O
how	O
metabolic	B:C1513158
control	I:C1513158
at	O
onset	O
of	O
type	O
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	O
control	I:C1513158
and	O
clinical	O
parameters	O
during	O
childhood	O
until	O
transition	O
from	O
pediatric	O
care	I:C3839839
to	O
adult	O
diabetes	O
care	I:C0150544
.	O

To	O
study	O
how	O
metabolic	O
control	I:C1513158
at	O
onset	O
of	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	O
control	I:C1513158
and	O
clinical	O
parameters	O
during	O
childhood	O
until	O
transition	O
from	O
pediatric	O
care	I:C3839839
to	O
adult	O
diabetes	O
care	I:C0150544
.	O

To	O
study	O
how	O
metabolic	O
control	I:C1513158
at	O
onset	O
of	O
type	O
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	B:C1513158
control	I:C1513158
and	O
clinical	O
parameters	O
during	O
childhood	O
until	O
transition	O
from	O
pediatric	O
care	I:C3839839
to	O
adult	O
diabetes	O
care	I:C0150544
.	O

To	O
study	O
how	O
metabolic	O
control	I:C1513158
at	O
onset	O
of	O
type	O
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	O
control	I:C1513158
and	O
clinical	O
parameters	B:C0449381
during	O
childhood	O
until	O
transition	O
from	O
pediatric	O
care	I:C3839839
to	O
adult	O
diabetes	O
care	I:C0150544
.	O

To	O
study	O
how	O
metabolic	O
control	I:C1513158
at	O
onset	O
of	O
type	O
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	O
control	I:C1513158
and	O
clinical	O
parameters	O
during	O
childhood	O
until	O
transition	O
from	O
pediatric	B:C3839839
care	I:C3839839
to	O
adult	O
diabetes	O
care	I:C0150544
.	O

To	O
study	O
how	O
metabolic	O
control	I:C1513158
at	O
onset	O
of	O
type	O
1	I:C0011854
diabetes	I:C0011854
correlates	O
to	O
metabolic	O
control	I:C1513158
and	O
clinical	O
parameters	O
during	O
childhood	O
until	O
transition	O
from	O
pediatric	O
care	I:C3839839
to	O
adult	O
diabetes	B:C0150544
care	I:C0150544
.	O

Data	O
at	O
onset	O
,	O
three	O
months	O
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	O
after	O
diagnosis	B:C0011900
and	O
at	O
transition	O
,	O
on	O
HbA1c	O
and	O
clinical	O
parameters	O
,	O
on	O
8084	O
patients	O
in	O
the	O
Swedish	O
pediatric	I:C0282574
quality	I:C0282574
registry	I:C0282574
,	I:C0282574
SWEDIABKIDS	I:C0282574
,	O
were	O
used	O
.	O

Data	O
at	O
onset	O
,	O
three	O
months	O
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	O
after	O
diagnosis	O
and	O
at	O
transition	O
,	O
on	O
HbA1c	B:C0019018
and	O
clinical	O
parameters	O
,	O
on	O
8084	O
patients	O
in	O
the	O
Swedish	O
pediatric	I:C0282574
quality	I:C0282574
registry	I:C0282574
,	I:C0282574
SWEDIABKIDS	I:C0282574
,	O
were	O
used	O
.	O

Data	O
at	O
onset	O
,	O
three	O
months	O
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	O
after	O
diagnosis	O
and	O
at	O
transition	O
,	O
on	O
HbA1c	O
and	O
clinical	O
parameters	B:C0449381
,	O
on	O
8084	O
patients	O
in	O
the	O
Swedish	O
pediatric	I:C0282574
quality	I:C0282574
registry	I:C0282574
,	I:C0282574
SWEDIABKIDS	I:C0282574
,	O
were	O
used	O
.	O

Data	O
at	O
onset	O
,	O
three	O
months	O
,	O
one	O
,	O
three	O
,	O
and	O
five	O
years	O
after	O
diagnosis	O
and	O
at	O
transition	O
,	O
on	O
HbA1c	O
and	O
clinical	O
parameters	O
,	O
on	O
8084	O
patients	O
in	O
the	O
Swedish	B:C0282574
pediatric	I:C0282574
quality	I:C0282574
registry	I:C0282574
,	I:C0282574
SWEDIABKIDS	I:C0282574
,	O
were	O
used	O
.	O

Of	O
these	O
patients	O
,	O
26	O
%	O
had	O
been	O
referred	O
to	O
adult	O
diabetes	B:C0150544
care	I:C0150544
by	O
2014	O
.	O

Children	O
with	O
HbA1c	B:C0019018
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	B:C1257890
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	B:C0011900
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	B:C1513158
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	B:C0019018
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	B:C1257890
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	B:C0011900
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	B:C0019018
at	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Children	O
with	O
HbA1c	O
<	O
72	O
mmol	O
/	O
mol	O
(	O
8.7	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
low	O
group	O
)	O
at	O
diagnosis	O
continued	O
to	O
have	O
good	O
metabolic	O
control	I:C1513158
during	O
childhood	O
,	O
in	O
contrast	O
to	O
children	O
with	O
HbA1	O
c	I:C0019018
>	O
114	O
mmol	O
/	O
mol	O
(	O
12.6	O
%	O
)	O
(	O
20	O
%	O
of	O
patients	O
,	O
high	O
group	O
)	O
at	O
diagnosis	O
,	O
who	O
continued	O
to	O
have	O
high	O
HbA1c	O
at	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

For	O
the	O
individual	B:C0237401
,	O
there	O
was	O
no	O
significant	I:C1273937
correlation	O
between	O
high	O
HbA1c	O
at	O
onset	O
and	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

For	O
the	O
individual	O
,	O
there	O
was	O
no	B:C1273937
significant	I:C1273937
correlation	O
between	O
high	O
HbA1c	O
at	O
onset	O
and	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

For	O
the	O
individual	O
,	O
there	O
was	O
no	O
significant	I:C1273937
correlation	O
between	O
high	O
HbA1c	B:C0019018
at	O
onset	O
and	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

For	O
the	O
individual	O
,	O
there	O
was	O
no	O
significant	I:C1273937
correlation	O
between	O
high	O
HbA1c	O
at	O
onset	O
and	O
during	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

During	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	O
were	O
more	O
often	O
smokers	O
,	O
less	O
physically	O
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	O
than	O
children	O
in	O
the	O
low	O
group	O
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

During	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	B:C1257890
were	O
more	O
often	O
smokers	O
,	O
less	O
physically	O
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	O
than	O
children	O
in	O
the	O
low	O
group	O
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

During	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	O
were	O
more	O
often	O
smokers	B:C0337664
,	O
less	O
physically	O
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	O
than	O
children	O
in	O
the	O
low	O
group	O
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

During	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	O
were	O
more	O
often	O
smokers	O
,	O
less	O
physically	B:C0556453
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	O
than	O
children	O
in	O
the	O
low	O
group	O
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

During	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	O
were	O
more	O
often	O
smokers	O
,	O
less	O
physically	O
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	B:C0035309
than	O
children	O
in	O
the	O
low	O
group	O
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

During	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
children	O
in	O
the	O
high	O
group	O
were	O
more	O
often	O
smokers	O
,	O
less	O
physically	O
active	I:C0556453
,	O
and	O
more	O
often	O
had	O
retinopathy	O
than	O
children	O
in	O
the	O
low	O
group	B:C1257890
(	O
P	O
<	O
.01	O
,	O
.01	O
,	O
.03	O
respectively	O
)	O
.	O

High	O
HbA1c	B:C0019018
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	O
control	I:C1513158
on	O
an	O
individual	O
level	O
.	O

High	O
HbA1c	O
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	B:C0019018
during	O
follow	O
-	I:C1522577
up	I:C1522577
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	O
control	I:C1513158
on	O
an	O
individual	O
level	O
.	O

High	O
HbA1c	O
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	O
during	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	O
control	I:C1513158
on	O
an	O
individual	O
level	O
.	O

High	O
HbA1c	O
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
on	O
a	O
group	B:C1257890
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	O
control	I:C1513158
on	O
an	O
individual	O
level	O
.	O

High	O
HbA1c	O
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	B:C1513158
control	I:C1513158
on	O
an	O
individual	O
level	O
.	O

High	O
HbA1c	O
at	O
onset	O
was	O
associated	O
with	O
high	O
HbA1c	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
on	O
a	O
group	O
level	O
,	O
but	O
it	O
cannot	O
be	O
used	O
as	O
a	O
predictor	O
of	O
future	O
metabolic	O
control	I:C1513158
on	O
an	O
individual	B:C0237401
level	O
.	O

These	O
results	O
emphasize	O
the	O
important	O
work	O
done	O
by	O
the	O
diabetes	B:C0011847
team	O
in	O
the	O
first	O
years	O
after	O
diagnosis	O
.	O

These	O
results	O
emphasize	O
the	O
important	O
work	O
done	O
by	O
the	O
diabetes	O
team	O
in	O
the	O
first	O
years	O
after	O
diagnosis	B:C0011900
.	O

It	O
is	O
important	O
to	O
continuously	O
set	O
high	O
goals	B:C0018017
for	O
the	O
achievement	O
of	O
tight	O
metabolic	O
control	I:C1513158
,	O
in	O
order	O
to	O
decrease	O
the	O
risk	O
of	O
microvascular	O
complications	O
.	O

It	O
is	O
important	O
to	O
continuously	O
set	O
high	O
goals	O
for	O
the	O
achievement	O
of	O
tight	O
metabolic	B:C1513158
control	I:C1513158
,	O
in	O
order	O
to	O
decrease	O
the	O
risk	O
of	O
microvascular	O
complications	O
.	O

